Superworth

Aethlon Medical AEMD

Medical - Instruments & Supplies, Healthcare
$5.05
−2.70%
Market cap
$3.6M
PE
n/m
one or more of the four quarters through 2026-06-30 missing
Forward PE
n/m
not a meaningful number
Price to sales
n/m
one or more of the four quarters through 2026-06-30 missing
EV/EBIT
n/m
a loss over the last year
Revenue, 12 months
n/m
one or more of the four quarters through 2026-06-30 missing
Net margin
n/m
one or more of the four quarters through 2026-06-30 missing
Free cash flow yield
n/m
not a meaningful number

Charts

Financials

Income statement for AEMD, by quarter
Income statementQ2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
n/an/an/an/an/an/an/an/an/an/an/an/a
SG&A$850.8K−45%$979.2K−9%$764.9K−8%$752K−43%$958.4K+13%$816.4K−17%$718K−6%$735.4K−2%$521.4K−46%$741.6K−9%$698K−3%$662.5K−10%
−$3.2M−13%−$3.6M+25%−$2.5M+0%−$2.6M−23%−$2.9M−9%−$1.8M−49%−$2M−19%−$1.8M−32%−$1.5M−48%−$2.1M+14%−$1.9M−4%−$1.6M−12%
Interest expensen/an/an/an/an/an/an/an/an/an/an/an/a
Net income−$3M−20%−$3.5M+22%−$2.4M−2%−$2.6M−22%−$2.8M−8%−$1.8M−49%−$6.3M+158%−$1.8M−32%−$1.5M−47%−$2M+15%−$1.9M−70%−$1.5M−12%
−$488.00−32%−$548.00+14%−$372.00−13%−$138.00−74%−$80.55−84%−$50.25−91%−$171.50−54%−$42.42−69%−$18.70−77%−$12.25−76%n/a−$4.02−91%
6.2K+20%6.3K+10%6.6K+14%18.6K+207%34.8K+461%34.9K+455%36.4K+457%41.5K+123%79.5K+128%164.6K+372%n/a384.7K+826%

Net income: 3 periods, Q3 FY21 to Q2 FY23: not printed by the filing, worked out from its own lines.

EPS, diluted: 16 periods, Q4 FY11 to Q4 FY25: quarter's net income to common over its shares, to the cent.

Diluted shares: 7 periods, Q2 FY11 to Q1 FY14: not printed by the filing, worked out from its own lines. Q4 FY11: share-days: the 12-month average less the 9-month, weighted by days. 11 periods, Q4 FY12 to Q4 FY24: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q2 FY14 and Q3 FY14: a loss quarter: its basic count, printed 3 months. Q4 FY14: share-days: the 12-month average over 365 days less the 9-month over 275, the two on one basis (x50). Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average over 365 days less the 9-month over 275, the two on one basis (x8).

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in Healthcare nearest Aethlon Medical's size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
AEMDAethlon Medical$3.6Mn/mn/an/mn/mn/m
OXBROXBRIDGE RE HOLDINGS$7.7M47.5×9.6×2.8×+40%4.7%
EDUCEducational Development$8.7M5.4×11.3×0.4×−32%8.6%
GTIMGood Times Restaurants$13.6M6.1×13.6×0.1×−6%1.7%
MDRRMedalist Diversified$15.4M2.5×3.0×1.6×−1%80.2%
BCGBinah Capital$18.2M6.7×20.8×0.1×+8%2.2%
VIPVulcan Infrastructure & Power$19.6M17.9×24.4×0.4×−14%1.0%
MXCMexco Energy$20.5M13.4×13.3×3.0×−9%23.3%
CKXCKX Lands$21.5M7.4×32.6×31.0×−17%n/m
MSGMMotorsport Games$22.5M11.4×11.5×1.5×+79%16.2%
ATCHAtlasClear$24M15.8×17.5×1.2×+85%9.8%
Peer median$18.9M9.4×13.4×1.4×−3%8.6%

More on Aethlon Medical

Each number over time

Its groups

About

Industry
Medical - Instruments & Supplies
Sector
Healthcare

Valuation data, not investment advice. Prices as of .